142 related articles for article (PubMed ID: 23194742)
1. Ancient origin of a Japanese xeroderma pigmentosum founder mutation.
Imoto K; Nadem C; Moriwaki S; Nishigori C; Oh KS; Khan SG; Goldstein AM; Kraemer KH
J Dermatol Sci; 2013 Feb; 69(2):175-6. PubMed ID: 23194742
[No Abstract] [Full Text] [Related]
2. Increased risk of skin cancer in Japanese heterozygotes of xeroderma pigmentosum group A.
Hirai Y; Noda A; Kodama Y; Cordova KA; Cullings HM; Yonehara S; Fujihara M; Moriwaki SI; Nishigori C; Mabuchi K; Kraemer KH; Nakamura N
J Hum Genet; 2018 Nov; 63(11):1181-1184. PubMed ID: 30089811
[TBL] [Abstract][Full Text] [Related]
3. Importance of genotype-phenotype correlation in xeroderma pigmentosum.
Fassihi H
Br J Dermatol; 2015 Apr; 172(4):859-60. PubMed ID: 25827741
[No Abstract] [Full Text] [Related]
4. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population.
Hirai Y; Kodama Y; Moriwaki S; Noda A; Cullings HM; Macphee DG; Kodama K; Mabuchi K; Kraemer KH; Land CE; Nakamura N
Mutat Res; 2006 Oct; 601(1-2):171-8. PubMed ID: 16905156
[TBL] [Abstract][Full Text] [Related]
6. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum in South Africa: Evidence for a prevalent founder effect.
Kgokolo M; Morice-Picard F; Rezvani HR; Austerlitz F; Cartault F; Sarasin A; Sathekge M; Taieb A; Ged C
Br J Dermatol; 2019 Nov; 181(5):1070-1072. PubMed ID: 31017654
[No Abstract] [Full Text] [Related]
9. Founder mutations in xeroderma pigmentosum.
Tamura D; DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2010 Jun; 130(6):1491-3. PubMed ID: 20463673
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
11. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
12. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
13. Genetics and skin cancer of xeroderma pigmentosum in Japan.
Takebe H; Nishigori C; Satoh Y
Jpn J Cancer Res; 1987 Nov; 78(11):1135-43. PubMed ID: 3121549
[No Abstract] [Full Text] [Related]
14. Xeroderma pigmentosum: a heterogeneous disease with pockets of homogeneity.
Barron GS; Kirsner RS
J Invest Dermatol; 2010 Jun; 130(6):1484. PubMed ID: 20463670
[No Abstract] [Full Text] [Related]
15. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms.
Takahashi Y; Endo Y; Sugiyama Y; Inoue S; Iijima M; Tomita Y; Kuru S; Takigawa M; Moriwaki S
J Invest Dermatol; 2010 Oct; 130(10):2481-8. PubMed ID: 20574439
[TBL] [Abstract][Full Text] [Related]
16. Neurological manifestations of xeroderma pigmentosum due to
Salomão RPA; Pedroso JL; Barsottini OGP
Pract Neurol; 2018 Dec; 18(6):489-491. PubMed ID: 30077970
[No Abstract] [Full Text] [Related]
17. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
[TBL] [Abstract][Full Text] [Related]
18. A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report.
Doubaj Y; Smaili W; Laarabi FZ; Sefiani A
J Med Case Rep; 2017 Jun; 11(1):158. PubMed ID: 28615033
[TBL] [Abstract][Full Text] [Related]
19. Four types of possible founder mutations are responsible for 87% of Japanese patients with Xeroderma pigmentosum variant type.
Masaki T; Ono R; Tanioka M; Funasaka Y; Nagano T; Moriwaki S; Nishigori C
J Dermatol Sci; 2008 Nov; 52(2):144-8. PubMed ID: 18703314
[No Abstract] [Full Text] [Related]
20. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
